Results 241 to 250 of about 509,395 (261)
Some of the next articles are maybe not open access.

FDA "Reform"?

Science, 1998
S M, Feinstone   +4 more
openaire   +2 more sources

Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class

New England Journal of Medicine, 2019
Jean Kim, Andrew Potter, Robert Temple
exaly  

First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication

New England Journal of Medicine, 2017
Richard Pazdur   +2 more
exaly  

Failing the Public Health — Rofecoxib, Merck, and the FDA

New England Journal of Medicine, 2004
Eric Topol
exaly  

The FDA Breakthrough-Drug Designation — Four Years of Experience

New England Journal of Medicine, 2018
Jonathan J Darrow, Aaron Seth Kesselheim
exaly  

FDA section

American Intra-Ocular Implant Society Journal, 1978
openaire   +2 more sources

FDA Oversight of Postmarketing Studies

New England Journal of Medicine, 2017
Mwango Kashoki, Peter Stein
exaly  

How the FDA Evaluates Drugs Related to Cancer

Ca-A Cancer Journal for Clinicians, 1967
exaly  

The FDA Sentinel Initiative — An Evolving National Resource

New England Journal of Medicine, 2018
Robert Ball   +2 more
exaly  

Addressing the FDA

Journal of Renal Nutrition, 2014
openaire   +2 more sources

Home - About - Disclaimer - Privacy